Bekker, A., Capparelli, E. V., Mirochnick, M., Clarke, D. F., Cotton, M. F., Shapiro, R., McCarthy, K., Moye, J., Violari, A., Chokephaibulkit, K., Abrams, E., Penazzato, M., Ruel, T. D., & Cressey, T. R. (2024). Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study. Journal of Antimicrobial Chemotherapy, 79(10), 2570–2574. https://doi.org/10.1093/jac/dkae259

Theodore, D. A., Henneman, A. D., Loo, A., Shields, R. K., Eschenauer, G., Sobieszczyk, M. E., & Kubin, C. J. (2024). Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia. Journal of Antimicrobial Chemotherapy, 79(8), 1877–1884. https://doi.org/10.1093/jac/dkae175

Gomez-Simmonds, A., Annavajhala, M. K., Tang, N., Rozenberg, F. D., Ahmad, M., Park, H., Lopatkin, A. J., & Uhlemann, A. C. (2022). Population structure ofblaKPC-harbouring IncN plasmids at a New York City medical centre and evidence for multi-species horizontal transmission. Journal of Antimicrobial Chemotherapy, 77(7), 1873–1882. https://doi.org/10.1093/jac/dkac114